These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 29636390
1. A nanoscale reorganization of the IL-15 receptor is triggered by NKG2D in a ligand-dependent manner. Bálint Š, Lopes FB, Davis DM. Sci Signal; 2018 Apr 10; 11(525):. PubMed ID: 29636390 [Abstract] [Full Text] [Related]
2. c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells. Molfetta R, Quatrini L, Capuano C, Gasparrini F, Zitti B, Zingoni A, Galandrini R, Santoni A, Paolini R. Eur J Immunol; 2014 Sep 10; 44(9):2761-70. PubMed ID: 24846123 [Abstract] [Full Text] [Related]
3. Human Natural Killer cell expression of ULBP2 is associated with a mature functional phenotype. Brennan K, McSharry BP, Keating S, Petrasca A, O'Reilly VP, Keane J, Doherty DG, Gardiner CM. Hum Immunol; 2016 Oct 10; 77(10):876-885. PubMed ID: 27349945 [Abstract] [Full Text] [Related]
4. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. Matusali G, Tchidjou HK, Pontrelli G, Bernardi S, D'Ettorre G, Vullo V, Buonomini AR, Andreoni M, Santoni A, Cerboni C, Doria M. FASEB J; 2013 Jun 10; 27(6):2440-50. PubMed ID: 23395909 [Abstract] [Full Text] [Related]
5. The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells. Fernández-Messina L, Ashiru O, Agüera-González S, Reyburn HT, Valés-Gómez M. J Cell Sci; 2011 Feb 01; 124(Pt 3):321-7. PubMed ID: 21224393 [Abstract] [Full Text] [Related]
6. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection. Campbell TM, McSharry BP, Steain M, Slobedman B, Abendroth A. J Virol; 2015 Aug 01; 89(15):7932-43. PubMed ID: 25995251 [Abstract] [Full Text] [Related]
7. A conserved WW domain-like motif regulates invariant chain-dependent cell-surface transport of the NKG2D ligand ULBP2. Uhlenbrock F, van Andel E, Andresen L, Skov S. Mol Immunol; 2015 Aug 01; 66(2):418-27. PubMed ID: 25983110 [Abstract] [Full Text] [Related]
8. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells. Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, Nausch N, Tuettenberg J, Steinle A, Cerwenka A, Schadendorf D, Paschen A. Int J Cancer; 2009 Apr 01; 124(7):1594-604. PubMed ID: 19089914 [Abstract] [Full Text] [Related]
9. Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition. Raneros AB, Minguela A, Rodriguez RM, Colado E, Bernal T, Anguita E, Mogorron AV, Gil AC, Vidal-Castiñeira JR, Márquez-Kisinousky L, Bulnes PD, Marin AM, Garay MCG, Suarez-Alvarez B, Lopez-Larrea C. Oncotarget; 2017 May 09; 8(19):31959-31976. PubMed ID: 28404876 [Abstract] [Full Text] [Related]
10. Interleukin 10 decreases MICA expression on melanoma cell surface. Serrano AE, Menares-Castillo E, Garrido-Tapia M, Ribeiro CH, Hernández CJ, Mendoza-Naranjo A, Gatica-Andrades M, Valenzuela-Diaz R, Zúñiga R, López MN, Salazar-Onfray F, Aguillón JC, Molina MC. Immunol Cell Biol; 2011 Mar 09; 89(3):447-57. PubMed ID: 20714339 [Abstract] [Full Text] [Related]
11. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications. Chitadze G, Bhat J, Lettau M, Janssen O, Kabelitz D. Scand J Immunol; 2013 Aug 09; 78(2):120-9. PubMed ID: 23679194 [Abstract] [Full Text] [Related]
12. Natural killer group 2D receptor and its ligands in cancer immune escape. Duan S, Guo W, Xu Z, He Y, Liang C, Mo Y, Wang Y, Xiong F, Guo C, Li Y, Li X, Li G, Zeng Z, Xiong W, Wang F. Mol Cancer; 2019 Feb 27; 18(1):29. PubMed ID: 30813924 [Abstract] [Full Text] [Related]
13. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. Rölle A, Mousavi-Jazi M, Eriksson M, Odeberg J, Söderberg-Nauclér C, Cosman D, Kärre K, Cerboni C. J Immunol; 2003 Jul 15; 171(2):902-8. PubMed ID: 12847260 [Abstract] [Full Text] [Related]
14. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells. Zhu S, Denman CJ, Cobanoglu ZS, Kiany S, Lau CC, Gottschalk SM, Hughes DP, Kleinerman ES, Lee DA. Pharm Res; 2015 Mar 15; 32(3):779-92. PubMed ID: 24203492 [Abstract] [Full Text] [Related]
15. Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Heinemann A, Zhao F, Pechlivanis S, Eberle J, Steinle A, Diederichs S, Schadendorf D, Paschen A. Cancer Res; 2012 Jan 15; 72(2):460-71. PubMed ID: 22102694 [Abstract] [Full Text] [Related]
16. NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8+ T cell migration. Vadstrup K, Galsgaard ED, Jensen H, Lanier LL, Ryan JC, Chen SY, Nolan GP, Vester-Andersen MK, Pedersen JS, Gerwien J, Jensen T, Bendtsen F. Exp Mol Pathol; 2017 Aug 15; 103(1):56-70. PubMed ID: 28684217 [Abstract] [Full Text] [Related]
17. Upregulation of the NKG2D Ligand ULBP2 by JC Polyomavirus Infection Promotes Immune Recognition by Natural Killer Cells. Jost S, Ahn J, Chen S, Yoder T, Gikundiro KE, Lee E, Gressens SB, Kroll K, Craemer M, Kaynor GC, Lifton M, Tan CS. J Infect Dis; 2024 Jun 14; 229(6):1836-1844. PubMed ID: 37774496 [Abstract] [Full Text] [Related]
18. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications. Jimenez-Perez MI, Jave-Suarez LF, Ortiz-Lazareno PC, Bravo-Cuellar A, Gonzalez-Ramella O, Aguilar-Lemarroy A, Hernandez-Flores G, Pereira-Suarez AL, Daneri-Navarro A, del Toro-Arreola S. BMC Immunol; 2012 Feb 08; 13():7. PubMed ID: 22316211 [Abstract] [Full Text] [Related]
19. Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling. Qin H, Lee IF, Panagiotopoulos C, Wang X, Chu AD, Utz PJ, Priatel JJ, Tan R. Diabetes; 2011 Mar 08; 60(3):857-66. PubMed ID: 21270236 [Abstract] [Full Text] [Related]
20. Natural killer cell-mediated shedding of ULBP2. Wang R, Sun PD. PLoS One; 2014 Mar 08; 9(3):e91133. PubMed ID: 24614922 [Abstract] [Full Text] [Related] Page: [Next] [New Search]